Compliance Rate

Compliance Rate 0.0%
Compliant submissions 0
Incompliant submissions 1
Total trials 1

My Organizations' Clinical Trials

Showing 350 of 361 entries
View as:

A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy

Phase: N/A Priority: Normal
NCT ID: NCT00150644 Org: User:
Start: 07/31/03 End: 05/31/05 Due: 05/31/06

Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-related Pain

Phase: N/A Priority: Normal
NCT ID: NCT06952296 Org: User:
Start: 04/30/25 End: 06/30/26 Due: 06/30/27

A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.

Phase: N/A Priority: Normal
NCT ID: NCT00156182 Org: User:
Start: 04/30/01 End: 12/31/01 Due: 12/31/02

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

Phase: N/A Priority: Normal
NCT ID: NCT00566722 Org: User:
Start: 01/31/08 End: 04/30/09 Due: 04/30/10

A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333

Phase: N/A Priority: Normal
NCT ID: NCT00768690 Org: User:
Start: 10/31/08 End: - Due: -

Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00385736 Org: User:
Start: 11/30/06 End: 03/31/10 Due: 03/31/11

Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00235820 Org: User:
Start: 07/31/05 End: - Due: -

IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine and/or Episodic Tension-type Headache and Patients' Satisfaction With the Treatment in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT02115269 Org: User:
Start: 06/30/14 End: 11/30/15 Due: 11/30/16

Comparative Study of the Safety and Efficacy of Clarithromycin Extended-Release Tablets Versus Amoxicillin-Clavulanate for the Treatment of Acute Bacterial Sinusitis

Phase: N/A Priority: Normal
NCT ID: NCT00644553 Org: User:
Start: 05/31/03 End: - Due: -

A Study of Pain Relief in Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT00298974 Org: User:
Start: 02/28/06 End: 05/31/07 Due: 05/31/08

Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care

Phase: N/A Priority: Normal
NCT ID: NCT01163916 Org: User:
Start: 01/31/08 End: 11/30/11 Due: 11/30/12

Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vestibular Vertigo in Routine Practice

Phase: N/A Priority: Normal
NCT ID: NCT01759251 Org: User:
Start: 01/31/13 End: 05/31/14 Due: 05/31/15

Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing

Phase: N/A Priority: Normal
NCT ID: NCT00647270 Org: User:
Start: 12/31/07 End: 04/30/09 Due: 04/30/10

Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT00626392 Org: User:
Start: 02/29/08 End: 04/30/08 Due: 04/30/09

Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy Human Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05519514 Org: User:
Start: 07/12/21 End: 11/15/21 Due: 11/15/22

Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01076959 Org: User:
Start: 06/30/08 End: 06/30/11 Due: 06/30/12

Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)

Phase: N/A Priority: Normal
NCT ID: NCT00234871 Org: User:
Start: 01/31/04 End: - Due: -

Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01647360 Org: User:
Start: 06/30/12 End: 05/31/13 Due: 05/31/14

A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Patients Treated With Eprosartan

Phase: N/A Priority: Normal
NCT ID: NCT01562613 Org: User:
Start: 03/31/12 End: 03/31/13 Due: 03/31/14

Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00754104 Org: User:
Start: 09/30/08 End: - Due: -

Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Food on the Pharmacokinetics of ABT-072

Phase: N/A Priority: Normal
NCT ID: NCT00982826 Org: User:
Start: 09/30/09 End: 01/31/10 Due: 01/31/11

A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Humanized Anti-CS1 Monoclonal IgG1 Antibody) and Bortezomib in Subjects With Multiple Myeloma Following One to Three Prior Therapies.

Phase: N/A Priority: Normal
NCT ID: NCT00726869 Org: User:
Start: 05/31/08 End: 03/31/12 Due: 03/31/13

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients

Phase: N/A Priority: Normal
NCT ID: NCT00234923 Org: User:
Start: 08/31/03 End: - Due: -

Safety of Treatment of Uterine Fibroids With Asoprisnil

Phase: N/A Priority: Normal
NCT ID: NCT00156208 Org: User:
Start: 04/30/04 End: 12/31/06 Due: 12/31/07

A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media

Phase: N/A Priority: Normal
NCT ID: NCT00645112 Org: User:
Start: 11/30/03 End: - Due: -